Cargando…

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer

EZH2, a core member of the Polycomb Repressor Complex 2 (PRC2), mediates transcriptional silencing by catalyzing the trimethylation of histone 3 lysine 27 (H3K27), which plays key roles in cancer initiation and progression. Here, we investigated the expression pattern and biological roles of EZH2 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhongwu, Wang, Yanling, Qiu, Jing, Li, Qiang, Yuan, Chunping, Zhang, Wei, Wang, Dongmiao, Ye, Jinhai, Jiang, Hongbin, Yang, Jianrong, Cheng, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926847/ https://www.ncbi.nlm.nih.gov/pubmed/24345883

Ejemplares similares

The pluripotency factor LIN28B is involved in oral carcinogenesis and associates with tumor aggressiveness and unfavorable prognosis
por: Wang, Dongmiao, et al.
Publicado: (2015)

Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma
por: Hu, Huijun, et al.
Publicado: (2017)

The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma
por: Li, Jin, et al.
Publicado: (2019)

The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
por: Steele, J C, et al.
Publicado: (2006)

An epidemiological and clinical analysis of craniomaxillofacial fibrous dysplasia in a Chinese population
por: Cheng, Jie, et al.
Publicado: (2012)

Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells
por: Zhu, Yumin, et al.
Publicado: (2018)

Going beyond Polycomb: EZH2 Functions in Prostate Cancer
por: Park, Su H., et al.
Publicado: (2021)

Identification of a Transcriptional Prognostic Signature From Five Metabolic Pathways in Oral Squamous Cell Carcinoma
por: Wu, Xiang, et al.
Publicado: (2020)

SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
por: Wu, Yaping, et al.
Publicado: (2018)

HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014)

Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013)

Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
por: Kim, Jung, et al.
Publicado: (2018)

Polycomb Group Protein Ezh2 Regulates Hepatic Progenitor Cell Proliferation and Differentiation in Murine Embryonic Liver
por: Koike, Hiroyuki, et al.
Publicado: (2014)

The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids
por: Yang, Qiwei, et al.
Publicado: (2016)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart
por: Mathiyalagan, Prabhu, et al.
Publicado: (2014)

Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
por: Zhang, Q, et al.
Publicado: (2014)

Deletion of the Polycomb-Group Protein EZH2 Leads to Compromised Self-Renewal and Differentiation Defects in Human Embryonic Stem Cells
por: Collinson, Adam, et al.
Publicado: (2016)

The functions of polycomb group proteins in T cells
por: Li, Ting
Publicado: (2022)

The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter
por: Gan, Lu, et al.
Publicado: (2018)

The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets
por: Van Dessel, Nele, et al.
Publicado: (2010)

Polycomb repressive complex’s evolutionary conserved function: the role of EZH2 status and cellular background
por: Gall Trošelj, Koraljka, et al.
Publicado: (2016)

Osteogenic Stimulation of Human Adipose‐Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2
por: Samsonraj, Rebekah M., et al.
Publicado: (2017)

EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
por: Mu, Weipeng, et al.
Publicado: (2018)

Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022)

Ezh2 programs T(FH) differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf
por: Li, Fengyin, et al.
Publicado: (2018)

p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor
por: Testoni, B, et al.
Publicado: (2011)

Polycomb Repressive Complex 2 Modulation through the Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021)

Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma
por: Huang, Rong, et al.
Publicado: (2020)

The Central Role of EED in the Orchestration of Polycomb Group Complexes
por: Cao, Qi, et al.
Publicado: (2014)

EZH2: novel therapeutic target for human cancer
por: Li, Long-Yuan
Publicado: (2014)

Polycomb group genes are required for neuronal pruning in Drosophila
por: Bu, Shufeng, et al.
Publicado: (2023)

Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme
por: Li, Gang, et al.
Publicado: (2013)

Polycomb group expression signatures in the malignant progression of gliomas
por: Hu, Qi, et al.
Publicado: (2017)

Evolution of Polycomb-group function in the green lineage
por: Schubert, Daniel
Publicado: (2019)

Mechanisms of Polycomb group protein function in cancer
por: Parreno, Victoria, et al.
Publicado: (2022)

Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2
por: Long, Yicheng, et al.
Publicado: (2017)

Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
por: Stojic, Lovorka, et al.
Publicado: (2011)

Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1
por: Zhang, Wei, et al.
Publicado: (2019)

Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
por: Wang, Sijie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3kkprkv3rilgrcbjhjv6f58pns